Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 318 participants.
Also called NCT04059913
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 318 participants
- Sponsor
- Registry
-
NCT04059913
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04059913. Randomized; no masking; primary purpose treatment. Start 2019-06-11 (actual); primary completion 2021-11-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease
- Condition
- CKD Anemia in Dialysis Participants
- Intervention (Drug)
- Roxadustat
- Lead sponsor
- Kyntra Bio
Record details
- Record id
cardio:ct-nct04059913- Content hash
bfc010cd4bb8d5e8c4e37993c353da03ddbb25f20161ebc19ae8bb3f2d524c35